Literature DB >> 11858835

Splicing regulation as a potential genetic modifier.

Malka Nissim-Rafinia1, Batsheva Kerem.   

Abstract

Inherited diseases are associated with profound phenotypic variability, which is affected strongly by genetic modifiers. The splicing machinery could be one such modifying system, through a mechanism involving splicing motifs and their interaction with a complex repertoire of splicing factors. Mutations in splicing motifs and changes in levels of splicing factors can result in different splicing patterns. Changes in the level of normal transcripts or in the relative pattern of different mRNA isoforms affect disease expression, leading to phenotypic variability. Here, we discuss the splicing machinery in terms of its significance in disease severity and its potential role as a genetic modifier.

Entities:  

Mesh:

Year:  2002        PMID: 11858835     DOI: 10.1016/s0168-9525(01)02619-1

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  59 in total

1.  Centromere-associated protein E expresses a novel mRNA isoform in acute lymphoblastic leukemia.

Authors:  Cindy E Jiménez-Ávila; Vanessa Villegas-Ruíz; Marta Zapata-Tarres; Alejandra E Rubio-Portillo; Eleazar I Pérez López; Juan C Zenteno; Sergio Juárez-Méndez
Journal:  Int J Mol Epidemiol Genet       Date:  2018-10-20

2.  The German cDNA network: cDNAs, functional genomics and proteomics.

Authors:  Stefan Wiemann; Stephanie Bechtel; Detlev Bannasch; Rainer Pepperkok; Annemarie Poustka
Journal:  J Struct Funct Genomics       Date:  2003

3.  Minimal introns are not "junk".

Authors:  Jun Yu; Zhiyong Yang; Miho Kibukawa; Marcia Paddock; Douglas A Passey; Gane Ka-Shu Wong
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

4.  Natural selection affects frequencies of AG and GT dinucleotides at the 5' and 3' ends of exons.

Authors:  S T Eskesen; F N Eskesen; A Ruvinsky
Journal:  Genetics       Date:  2004-05       Impact factor: 4.562

5.  Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1.

Authors:  Wei Ren; Liang-Hua Zhu; Hua-Guo Xu; Rui Jin; Guo-Ping Zhou
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 6.  Influence of RNA secondary structure on the pre-mRNA splicing process.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

7.  Three new alternative splicing variants of human cytochrome P450 2D6 mRNA in human extratumoral liver tissue.

Authors:  Jian Zhuge; Ying-Nian Yu
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 8.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

Review 9.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

Review 10.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.